Artificial Intelligence in bone Metastases: A systematic review in guideline adherence of 92 studies.

Journal: Journal of bone oncology
Published Date: Apr 24, 2025

Abstract

BACKGROUND: The last decade has witnessed a surge in artificial intelligence (AI). With bone metastases becoming more prevalent, there is an increasing call for personalized treatment options, a domain where AI can greatly contribute. However, integrating AI into clinical settings has proven to be difficult. Therefore, we aimed to provide an overview of AI modalities for treating bone metastases and recommend implementation-worthy models based on TRIPOD, CLAIM, and UPM scores.

Authors

  • Lotte R van der Linden
    Department of Orthopaedic Surgery, University Medical Center Groningen, Groningen, the Netherlands.
  • Ioannis Vavliakis
    Department of Orthopaedic Surgery, University Medical Center Groningen, Groningen, the Netherlands.
  • Tom M de Groot
    Department of Orthopaedic Surgery, Orthopaedic Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Paul C Jutte
    Department of Orthopaedic Surgery, Groningen University Medical Centre, Groningen, the Netherlands.
  • Job N Doornberg
  • Santiago A Lozano-Calderon
    Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Olivier Q Groot
    Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals